[Chinese guidelines for the diagnosis and treatment of vascular cognitive impairment (2024 edition)]

    PubMed

    Insights

    Vascular cognitive impairment (VCI) is a significant cause of cognitive decline in older adults. Updated guidelines offer standardized diagnosis and management strategies to improve patient outcomes.

    Area of Science:

    • Neurology
    • Geriatrics
    • Public Health

    Context:

    • Vascular cognitive impairment (VCI) is the second leading cause of cognitive impairment in individuals over 60 in China.
    • No specific treatments exist for VCI, highlighting the importance of early identification and prevention.
    • The Chinese Stroke Association Vascular Cognitive Impairment Subcommittee addressed the need for updated clinical guidance.

    Purpose:

    • To raise clinician awareness and attention regarding VCI.
    • To provide standardized management guidance for VCI.
    • To update clinical classification, diagnostic procedures, and evaluation criteria for VCI.

    Summary:

    • Revised guidelines are based on systematic literature reviews and evidence evaluation.
    • Eight recommendations cover VCI etiology, classification, manifestations, diagnosis, prevention, and treatment.
    • A standardized diagnostic process for VCI in China is proposed.

    Impact:

    • Aims to guide standardized diagnosis and accurate treatment of VCI.
    • Expected to improve early identification and prevention strategies.
    • Contributes to better patient prognosis and reduced VCI onset risk.

    Related Concept Videos

    Dementia01:30

    Dementia

    Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
    The progression of dementia is generally gradual....
    110
    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
    179
    Alzheimer's Disease: Overview01:26

    Alzheimer's Disease: Overview

    Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
    The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
    462
    Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

    Cardiovascular Drugs: Classification based on Therapeutic Indications

    Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
    2.4K